2024-12-10 2025-12-31 2025-12-31 true 16127733 Natida Healthcare Training & Recruitment Services Ltd 99999 Dormant Company iso4217:GBP xbrli:pure 16127733 2024-12-10 16127733 2025-12-31 16127733 2024-12-10 2025-12-31 16127733 bus:SmallEntities 2024-12-10 2025-12-31 16127733 bus:AuditExempt-NoAccountantsReport 2024-12-10 2025-12-31 16127733 bus:FullAccounts 2024-12-10 2025-12-31 16127733 core:WithinOneYear 2025-12-31 16127733 core:AfterOneYear 2025-12-31 16127733 core:WithinOneYear 2024-12-10 2025-12-31 16127733 core:AfterOneYear 2024-12-10 2025-12-31 16127733 core:CurrentFinancialInstruments 2025-12-31 16127733 core:Non-currentFinancialInstruments 2025-12-31 16127733 core:CurrentFinancialInstruments 2024-12-10 2025-12-31 16127733 core:Non-currentFinancialInstruments 2024-12-10 2025-12-31 16127733 core:LandBuildings 2024-12-10 2025-12-31 16127733 core:FurnitureFittings 2024-12-10 2025-12-31 16127733 core:OfficeEquipment 2024-12-10 2025-12-31 16127733 core:Vehicles 2024-12-10 2025-12-31 16127733 core:PlantMachinery 2024-12-10 2025-12-31 16127733 core:OtherPropertyPlantEquipment 2024-12-10 2025-12-31 16127733 core:LandBuildings 2025-12-31 16127733 core:PlantMachinery 2025-12-31 16127733 core:Vehicles 2025-12-31 16127733 core:FurnitureFittings 2025-12-31 16127733 core:OfficeEquipment 2025-12-31 16127733 core:OtherPropertyPlantEquipment 2025-12-31 16127733 core:Right-of-useAssets 2024-12-10 2025-12-31 16127733 core:Right-of-useAssets 2025-12-31 16127733 core:Goodwill 2024-12-10 2025-12-31 16127733 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-10 2025-12-31 16127733 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-10 2025-12-31 16127733 core:OtherResidualIntangibleAssets 2024-12-10 2025-12-31 16127733 core:Goodwill 2025-12-31 16127733 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 16127733 core:PatentsTrademarksLicencesConcessionsSimilar 2025-12-31 16127733 core:OtherResidualIntangibleAssets 2025-12-31 16127733 dpl:CostSales 2024-12-10 2025-12-31 16127733 dpl:AdministrativeExpenses 2024-12-10 2025-12-31 16127733 dpl:DistributionCosts 2024-12-10 2025-12-31 16127733 core:ShareCapital 2025-12-31 16127733 core:SharePremium 2025-12-31 16127733 core:RevaluationReserve 2025-12-31 16127733 core:OtherReservesSubtotal 2025-12-31 16127733 core:ShareCapitalPreferenceShares 2025-12-31 16127733 core:CapitalRedemptionReserve 2025-12-31 16127733 core:OtherCapitalReserve 2025-12-31 16127733 core:RetainedEarningsAccumulatedLosses 2025-12-31 16127733 core:ShareCapital 2024-12-10 2025-12-31 16127733 core:SharePremium 2024-12-10 2025-12-31 16127733 core:RevaluationReserve 2024-12-10 2025-12-31 16127733 core:OtherReservesSubtotal 2024-12-10 2025-12-31 16127733 core:RetainedEarningsAccumulatedLosses 2024-12-10 2025-12-31 16127733 1 2024-12-10 2025-12-31 16127733 2 2024-12-10 2025-12-31 16127733 core:ShareCapital 1 2024-12-10 2025-12-31 16127733 core:ShareCapital 2 2024-12-10 2025-12-31 16127733 core:SharePremium 1 2024-12-10 2025-12-31 16127733 core:SharePremium 2 2024-12-10 2025-12-31 16127733 core:RevaluationReserve 1 2024-12-10 2025-12-31 16127733 core:RevaluationReserve 2 2024-12-10 2025-12-31 16127733 core:RetainedEarningsAccumulatedLosses 1 2024-12-10 2025-12-31 16127733 core:RetainedEarningsAccumulatedLosses 2 2024-12-10 2025-12-31 16127733 1 2024-12-10 2025-12-31 16127733 core:Non-currentFinancialInstruments core:CostValuation 2024-12-10 16127733 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments core:CostValuation 2025-12-31 16127733 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2024-12-10 16127733 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments core:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal 2025-12-31 16127733 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2025-12-31 16127733 core:Non-currentFinancialInstruments 2025-12-31 16127733 core:Non-currentFinancialInstruments 2024-12-09 16127733 bus:Director1 2024-12-10 2025-12-31 16127733 bus:PrivateLimitedCompanyLtd 2024-12-10 2025-12-31
Natida Healthcare Training & Recruitment Services Ltd
Dormant Financial Statements
for the period ended 31 December 2025
Company registration number 16127733
(England and Wales)

# Company Information

For the period 10 December 2024 to 31 December 2025

Director | Kapochina, Christabel Ida

Registered office | Flat 29 Adagio Point
| 1 Bridge Walk
| London
| SE8 3FH

Registered number | 16127733

Accountant | 2020 ACCOUNTANCY
| Bourne Space
| Bourne House
| 23 Hinton Road
| Bournemouth
| Bournemouth
| BH1 2EF

# Statement of Financial Position

As at 31 December 2025

| Notes |
2025
£
£
Current assets
Debtors
| 4 |
1
1
Net current assets (liabilities)
1
Total assets less current liabilities
1
Net assets (liabilities)
1
Capital and reserves
Called up share capital
1
Total equity
1

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the director on 19 August 2026 and are signed on its behalf by:

Kapochina, Christabel Ida Kapochina, Christabel Ida Director |

Company registration number 16127733

# Notes to the Financial Statements

For the period 10 December 2024 to 31 December 2025

### 1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

### 2. Accounting policies

### 2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

### 3. Employees

The average number of employees during the year was 0.

### 4. Debtors

2025
£
Directors loan accounts
1
Total due within one year
1
Total due after one year
-
Total
1